Parenteral Drug Delivery

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/133

encourage image

There's no tags or description

Looks like no tags are added yet.

134 Terms

1
New cards

parenteral drug delivery

any drug delivery occurring outside of the GIT but typically used for injectable routes of drug delivery

2
New cards

how are drugs unstable in water prepared for parenteral drug delivery?

as a freeze dried powder for dissolution or suspension at the time of injection

3
New cards

how are drugs that are unstable in oxygen packaged for parenteral drug delivery?

packaged in nitrogen & sealed from the air & moisture

4
New cards

If an injectable suspension is formulated, the particles must be very ________

fine

5
New cards

USP name for a drug solution or liquid drug

[drug] injectin

6
New cards

USP name for a solids for dissolution prior to injection

[drug] for injection

7
New cards

USP name for an emulsion with dissolved or dispersed drug

[drug] injectable emulsion

8
New cards

USP name for a suspension of drug solids

[drug] injectable suspension

9
New cards

USP name for a solid for suspension prior to injection

[drug'] fr injectable suspension

10
New cards

intravenous

IV injections are given directly into a vein. Medications can be given in a variety of volumes. This route gives 100% bioavailability and the fastest onset of action.

11
New cards

intramuscular

given into a muscle, slower onset than IV injections, but still fairly rapid onset of action.

  • Drugs given via IM injection diffuse through the muscle tissue and are absorbed by capillaries within the muscle tissue.

  • The particular muscle used as the site of injection will control onset of action based upon that muscles’ relative density.


12
New cards

how does muscle density affect parenteral drug absorption?

More dense muscle tissue will result in slower absorption and faster blood flow in a muscle tissue will speed up absorption.

13
New cards

IM injected suspensions will have ________ absorption than solutions as the drug is not yet dissolved.


slower

14
New cards

subcutaneous

also called hypodermic injections, are given under the skin.

  • SC injectable solutions diffuse to veins in the subcutaneous region, while injectable suspensions must have the drug dissolve first before they absorb


15
New cards

intradermal

ID injections are given into the skin (unlike SC injections which are under the skin).

16
New cards

intrathecal

Intrathecal injections are injections into the intrathecal space of the spinal cord.

17
New cards

intra-spinal

given in the spinal column

18
New cards

intra-arterial

Injection into an artery rather than a vein.

19
New cards

intra-ocular

Injections into the eye, typically to treat a serious eye condition.

20
New cards

intra-cardiac

Injections into the heart, typically in emergency situations.

21
New cards

can oily injections be given IV?

no- oil can cause blood vessel blockages w potential for a fatal pulmonary embolism

22
New cards

can o/w emulsion be given IV?

yes, as long as the internal oil phase droplets are 1um or smaller so that it does not cause blod vessel blockages

23
New cards

additional stringent rules within GMP for injections

must be sterilized as the terminal step in manufacturing and manufactured in as clean an environment as possible.

24
New cards

components of injectable solutions

active ingredient and excipients dissolved in water for injection (WFI).

  • may have solubilizing agents


25
New cards

solubilizing agents (parenteral)

can be used as needed to improve the solubility or rate of solution of poorly soluble active compounds

26
New cards

The pH of the solution can be adjusted to improve dissolution, however it should be ________ with the tissue it will be injected into (parenteral)

isotonic

27
New cards

during manufacturing, injectables should be formulated in an __________ to lower the final microbial load for sterilization & mitigate endotoxins

ISO 8 class cleanroom

28
New cards

what helps limit cleaning requirements for injection manufacturing?

disposable sterile parts

29
New cards

for cleaning in parenteral manufacturing, what is used for initial and final rinses?

initial = USP purified water

final = USP water for injection (WFI)

30
New cards

can you use detergents in parenteral manufacturing?

no- avoid due to possibility of trace detergent making it into the final product

31
New cards

why must you limit time between washing/drying/sterilizing in parenteral manufacturing?

to prevent microbial growth

32
New cards

siliconization

a thin layer of silicone is added to syringe parts or portions of the packaging in order to improve the smoothness of syringe action. Silicone oil is typically used.

  • helps to ensure that vials and syringes are completely emptied and the entire dose is dispensed.


33
New cards

what parts are typically siliconized? (parenteral manufacturing)

  • vials

  • syringe barrels

  • stoppers

  • syringe needles


34
New cards

why are syringes overfilled?

to account for lost dose and siliconization minimizes the amount of overfill needed.

35
New cards

purpose of siliconizing syringe needles?

improve needle insertion

36
New cards

poorly soluble ing can use ________ to help improve mixing & rate of solution in parenteral injections

impellers

37
New cards

when compounding a parenteral solution, it is important to ensure that impeller does not form a ____________ in the solution and lead to trapped air within the soln

vortex

38
New cards

_________ may be used to improve dissolution of excipients/drugs as long as they are stable in the heat

elevated temp

39
New cards

filling of parenteral drugs

  1. Once the bulk solution is prepared, it can be transferred and packaged in containers, typically single dose vials with rubber stoppers or pre-filled syringes.

  2. Following filling, the final solution is then sterilized.


40
New cards

do single or multidose vials have more variability?

single

  • multidose vials have less significant variability as the variability makes up a smaller part of the whole volume


41
New cards

what are injectable susp used for?

drugs that do not readily dissolve or can be used for extended-release

42
New cards

how are suspensions typically administered?

IM or sometimes SC

43
New cards

what determines rate of absorption for a suspended drug?

rate of dissolution at the injection site

44
New cards

Similar to general pharmaceutical suspensions, particles can settle and may need a _________ to prevent particle caking.

suspending agent

45
New cards

why would you use a wetting agent in an injectable susp?

to ensure that particles are adequately dispersed

46
New cards

additional req for injectable susp

  • terility

  • isotonicity

  • pyrgen free

  • syringeable

  • stable over lifetime of product without caking/forming crystals

  • buffer


47
New cards

are suspensions terminally sterilized?

no— can lead to drug degradation

48
New cards

as suspensions are not terminally sterilized, what happens to them instead?

they are compounded from sterile ing using aseptic technique

49
New cards

what happens if susp particles are too large?

  • may not easily pass thru 18-21 gauge needle (300-600 um)

  • can be trapped on the rouge surfaces of the inside of the needle → buildup and clogging of syringe


50
New cards

what causes crystallization of injectable susp?


due to temperature variations during storage as small amounts of drug that dissolve can precipitate and form crystals.

51
New cards

how do susp try to prevent crystal growth?

  • have excipients designed to prevent it

  • may have a low conc of suspended particles to prevent crystal formation


52
New cards

why are injectable emulsions less commonly used?

it is hard to get the contained oil droplets smaller than 1 um

53
New cards

when are injectable emulsions commonly used?

for total parenteral nutrition (TPN) for patients who cannot consume food orally

54
New cards

how do emulsions work for TPN?

The oily interior phase allows for delivery of fatty acids and lipophilic nutrients.

55
New cards

caution for use of emulsions and TPN IV lines

oily droplets may coalesce and lead to embolisms

56
New cards

For powder formulations that will be made up into solutions or suspensions at the time of injection, powders are typically compounded…

sterilely as powders can not easily withstand terminal sterilization.

57
New cards

how can drug soln in an organic or non-aq solvent be sterilized? (preparation of sterile drug powder)

sterilized by filtration and then a nonsolvent can be added to cause the drug to precipitate or crystallize out of the solution.

  • The resulting crystals are sterile and can be used for compounding sterile powders.


58
New cards

powders for injection req solvent to be added at the time of _________ to dissolve the powder and form a soln w/o need for extensive mixing

injection

59
New cards

why is solvent added at time of injection for powder injection?

dissolves powder and forms a soln without need for extensive mixing

60
New cards

diff bw powder for injection and susp

powders for susp forms a susp instead of a soln and req suspending agents

  • must be able to remain stable across shelf life

  • utilize surfactants to prevent crystal growth


61
New cards

what do powder for susp use to prevent crystal growth?

surfactants

62
New cards

what happens to freeze dried formulations instead of terminal sterilization?

  • soln are sterilized by filtration

  • transferred to sterile packaging containers

  • freeze dried


63
New cards

temp for freeze drying to be done at

-20 - 40C

  • to prevent water formation


64
New cards

in freeze-dried formulation, after freeze drying, a second _________ step is used to remove any residual contained ___________

drying / water

65
New cards

why can’t freeze-dried formulations be isotonic?

too much added salt can decrease the temperature required for collapsing and forming the fluffy easily reconstituted solids too much.

66
New cards

why can only limited amt of buffer be used in freeze-dried formulations?

only so much buffer can easily be freeze-dried without losing buffer to the removed water as the solid freeze dries.

67
New cards

special glass vials used for freeze-drying contain __________

lyostoppers

  • allow sublimated water vapor to escape during freeze drying


68
New cards

packaging of freeze-dried

  • Special glass vials are used for freeze drying that 4 contain lyostoppers (stoppers for lyophilization or freeze-drying). These vials allow the sublimated water vapor to escape during freeze drying.

  • Vials with solution are placed in a freeze dryer which is operated at low temperature (-30 to -40C typically).

  • Once the product freezes, the chamber is placed under vacuum pressure and then heated to sublimate the liquid and leave the lyophilized solid in the vials.

  • The vials can then be subjected to a drying cycle to remove residual liquid and can be sealed while in the vacuum to prevent outside contamination.


69
New cards

key disadvantage of ER injection

inability to discontinue the medication after the dose is administered. The patient must wait for all of the dose to be released for the drug to clear their system.

70
New cards

Drugs for extended-release injections typically need to be ________ enough to deliver a small quantity injection that contains enough active ingredient for multiple doses over time

potent

71
New cards

req for ER injection drugs

  • must be potent enough to deliver a mall quantity injection that contains enough active ing for multiple doses over time

  • not readily metabolized after injection but before rel

  • must be stable in injectable formulation for duration of its shelf-life & duration of extended time in body

  • injection site irritation should be limited for the drug/easily managed


72
New cards

all ER injections are considered ______ delivery systems

depot

73
New cards

oily injections

oily solutions with the drug dissolved in a lipophilic solvent and are typically administered as IM or sometimes SC injections.

  • The oily solution when injected will disperse in the muscle or subcutaneous space and form a depot allowing for extended drug release


74
New cards

implications of partition coefficient for oily injections

the drug should not so greatly favor the oily vehicle that it does not absorb well into the tissues and blood vessels to systemic circulation

75
New cards

oily susp

require the drug to dissolve first prior to absorption slowing the rate of absorption

  • the drug release will be zero order as the limiting factor in drug absorption is drug dissolution


76
New cards

oily soln

the absorption rate will increase as drug content in the oil decrease

77
New cards

commonly used oils

vegetable oils such as peanut, corn, olive, cottonseed, or sesame oil or synthetic/semi-synthetic oils such as isopropyl myristate, ethyl oleate, and polyethylene glycols (PEGs)

78
New cards

storage for oily injectable formulations

store away from light & heat so oils don’t oxidize

79
New cards

req for oils in oily injections

  • non-irritant

  • don’t interact w drug

  • slowly eliminated from injection site

  • help to maintain an appropriate rel rate of drug over time


80
New cards

main issue with oily injection

injection site irritation than aqueous suspensions, so many suspensions are becoming more commonly used.

81
New cards

aqueous susp

depot injection formulation, not all are long acting (ex. insulin injections which are administered daily) but can be designed as depot formulation for ER over weeks

82
New cards

how should aqueous suspensions be formulated?

w adding viscosity enhancers to avoid caking to ensure that particles can easily be resuspended after a period of time

83
New cards

what type of viscosity enhancers are particularly useful for aqueous susp?

ones that exhibit thixotropy, in that they are more liquid under shearing forces such as being drawn up and ejected from a syringe, but are more viscous in the vial and at the site of 5 injection.

84
New cards

what happens to aqueous susp after administration?

the aqueous vehicle is absorbed and the particulates are left behind in the muscle or subcutaneous tissue.

85
New cards

microparticulate inj

made up of polymers containing the drug that are slowly degraded from the outside in allowing near zero order drug release over time.

86
New cards

how are polymers selected for microparticulates?

based upon the drug release profile desired

87
New cards

The longer the polymer chain the more ________ the microparticulate will be and the slower the drug will be released

viscous

88
New cards

Drug release is reliant on _________ of portions of the polymer chain making the polymer shorter and releasing drug as the polymer _________

cleavage / degrades

89
New cards

PGLA

lactic acid portion is more hydrophobic than the glycolic acid component.

  • 1 of the most commonly used polymers due to its biocompatibility and release profile


90
New cards

The more lipophilic polymers will _____ water penetration into the microparticulate and therefore will ______ the hydrolysis reactions that cleave and shorten the polymers allowing the drug to be released.

slow / slow

91
New cards

several methods for manufacturing microparticles

  • emulsion/solvent evaporation

  • spray drying

  • spray congealing

  • phase separation/coacervation

  • extrusion.


92
New cards

Emulsion/solvent evaporation (manufacturing method)

an o/w emulsion is formed using a volatile oil in the internal phase. The drug and polymer are dissolved in the oil and then the oil can be evaporated from the emulsion to form suspended microparticulates in the aqueous phase. The microparticulates can then be filtered out of the aqueous phase.

  • This process can be done in several more complex ways including using water in oil in water w/o/w emulsions.


93
New cards

spray drying/congealing (manufacturing method)

utilizes heat to evaporate solvent from a solution or suspension of drug and polymer while spray congealing takes molten drug and polymer and uses cooling to form highly spherical microparticulates using the molten liquid’s surface tension

94
New cards

phase separation/coacervation

polymers can be added to a non-solvent to form a precipitate. Drug can be added to the non-solvent and polymers will wrap around the drug prior to precipitation and adding more non-solvent will form solid particulates

95
New cards

extrusion

the polymer is melted and drug is dispersed into the melted polymer. The melted drug and polymer mixture can be placed in an extruder which maintains the melted phase and forces the material through a die forming strands of material that break up into smaller microparticulates.

96
New cards

Following development of an injectable formulation and packaging of the solution or suspension, the injectable formulation must be sterilized unless…

it is compounded using sterile ingredients with aseptic technique

97
New cards

Sterilization uses the ____________ to describe the relationship between the time of sterilization and the amount of microbes killed

decimal reduction value or D value

98
New cards

D value

the time of sterilization needed to ensure that only 10% of the viable microbes remain

99
New cards

moist heat sterilization (autoclaving)

kills microbes through coagulating and denaturing their proteins. Using moist heat allows the sterilization process to be completed under lower temperatures than those required for dry heat sterilization as the steam generated can penetrate materials.

100
New cards

For moist heat sterilization, the _________ the temperature used the shorter the duration of sterilization.

higher